Shahab Asgharzadeh MD
Assistant Professor, Pediatrics, USC School of Medicine
Join to View Full Profile
4650 W Sunset BlvdMs# 54Los Angeles, CA 90027
Phone+1 323-361-6477
Fax+1 323-660-7128
Dr. Asgharzadeh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 2001 - 2004
University of ChicagoResidency, Pediatrics, 1996 - 1999
University of Illinois College of MedicineClass of 1996
Certifications & Licensure
CA State Medical License 2001 - 2026
IL State Medical License 1996 - 2008
American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- Myeloid-targeting immunotherapies overcome inhibitory barriers in immune-evasive neuroblastoma.Marie Ménard, Hiroyuki Yoda, Nicole Nasholm, Megumi J Barata, Linyu Wang
The Journal of Experimental Medicine. 2025-09-01 - Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum.Steven G DuBois, Lucas Moreno, John Anderson, Shahab Asgharzadeh, Ro Bagatell
Pediatric Blood & Cancer. 2025-09-01 - Phase I Study ofI-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Thera...Thomas Cash, Araz Marachelian, Steven G DuBois, Yueh-Yun Chi, Anahit Baregamyan
Journal of Clinical Oncology. 2025-08-01
Press Mentions
Creating a Safe CAR T-cell Therapy to Fight Solid Tumors in ChildrenJanuary 22nd, 2021
Creating a Safe CAR T-cell Therapy to Fight Solid Tumors in ChildrenJanuary 21st, 2021
When Good Immune Cells Turn BadSeptember 21st, 2017- Join now to see all
Grant Support
- Pediatric Solid Tumor Microenvironment AtlasCHILDREN'S HOSPITAL OF LOS ANGELES2024–2029
- Clinical Implications of Natural Killer-derived exosomal miRNAs in NeuroblastomaCHILDREN'S RESEARCH INSTITUTE2024–2029
- Pediatric Solid Tumor Microenvironment AtlasCHILDREN'S HOSPITAL OF LOS ANGELES2024–2029
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
